Chemicals

8-Bromo-1-octene

We are 8-Bromo-1-octene CAS:2695-48-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 8-Bromo-1-octene

CAS.NO:2695-48-9

Synonyms:1-bromooct-7-ene

1-bromo-7-octene

8-Bromo-1-octene

7-Octenyl Bromide

8-bromo-oct-1-ene

Molecular Formula: C8H15Br

Molecular Weight: 191.10900

Physical and Chemical Properties:

Density:1.139 g/mL at 25 °C(lit.)

Boiling point:198.7ºC at 760 mmHg

Melting point:/

Flash point:78ºC

Index of Refraction:1.467

Specification:

Appearance:Colorless transparent liquid

Purity:≥97.0%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Keep the container closed. Store in a freezer-freezer.

Store in an inert atmosphere.

Keep away from incompatible materials such as oxidizers.

Application: 8-Bromo-1-octene, is a building block used for the synthesis of more complex pharmaceutical compounds, such as Dithienogermole (DTG) derivatives with varying alkyl chain lengths and pendant functionalities.

8-Bromo-1-octene

Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.4,5-dibromo-1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-one CAS:196597-77-0 In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.4-mercapto-4-methylpentan-2-one “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate CAS:88110-89-8 Active pharmaceutical ingredients directly impact disease.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.

Product Name
1-bromo-9H-carbazole Cas:16807-11-7	View Details
O-phosphoethanolamine Cas:1071-23-4	View Details
Cerium tetrahydroxide Cas:12014-56-1	View Details